Indivior | Lånekapital



Loan Capital Endring Dato
AstraZeneca USD 27.73B 2.29B 2024-12
Eli Lilly USD 28.53B 518.3M 2024-12
Glaxosmithkline GBP 14.64B 1.39B 2024-12
Halozyme Therapeutics USD 1.51B 1.64M 2024-12
Indivior 315M 45M 2024-12
J&J USD 30.65B 638M 2024-12
Kyowa Hakko Kirin JPY 24.12B 5.27B 2024-12
Merck USD 34.46B 520M 2024-12
Novartis USD 22.93B 2.41B 2024-12
Pfizer USD 57.4B 597M 2024-12
Sanofi 11.79B 712M 2024-12
Supernus Pharmaceuticals USD 0 0 2024-12



Indivior Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.